Oral Cancer Diagnosis & Treatment – Extreme Drug Resistance
Learn More About Oral Cancer Extreme Drug Resistance: Chat with Us | Email Us
Extreme Drug Resistance for Oral Cancer
The Extreme Drug Resistance (EDR) Assay (or chemoresistance test) is another innovative way Cancer Treatment Centers of America (CTCA) tailors a oral cancer treatment plan for each patient fighting oral cancer.
The EDR is a highly accurate test that determines the probability of a solid tumor’s resistance to specific chemotherapeutic drugs. If the cancerous cells multiply in the presence of extreme exposure to a drug, it indicates significant resistance to that drug. If the tumor is resistant to a drug in this assay, then the tumor growing in a patient’s body will almost certainly be resistant to that drug. This information allows your CTCA oncologists to avoid unnecessary toxicity, consider other oral cancer treatment protocols and minimize costs for patients.
Next Topic: MRI for Oral Cancer
